⌘K
A
ABIONYX Pharma
Healthcare & Life Sciences
Recent Finacing
Non-dilutive financing
Recent Raise
$9.1M
ABIONYX Pharma is a biotechnology company developing a recombinant apoA-I protein treatment for severe inflammation in sepsis patients.
Focus Areas
Recombinant protein
Sepsis treatment
Inflammation
Lipid metabolism
Bioproduction
Clinical trials
Investors
